Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: International Breast Cancer Study Group (IBCSG)
Woman Max 99 years
International Breast Cancer Study Group (IBCSG)
Update Il y a 5 ans
A trial comparing the efficacy between the two hormone drugs degarelix and triptorelin in patients having not yet entered the menopause and having not undergone surgery. Additional to each treatment the patients receive letrozole for locally advanced endocrine responsive breast cancer
To evaluate the endocrine activity of neoadjuvant letrozole plus either degarelix or triptorelin.
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
International Breast Cancer Study Group (IBCSG)
Update Il y a 5 ans
Phase III Trial Evaluating the Role of Adjuvant Pegylated Liposomal Doxorubicin (PLD, Caelyx®, Doxil®) for Women (age 66 years or older) with Endocrine Nonresponsive Breast Cancer Who Are NOT Suitable for Being Offered a “Standard Chemotherapy Regimen”
The overall aim of the CASA trial is to investigate the role of PLD as adjuvant chemotherapy for older postmenopausal women (66 years old and above). The stratified analysis combining the results of b...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
International Breast Cancer Study Group (IBCSG)
Update Il y a 5 ans
A randomized phase III trial of exemestane versus anastrozole in postmenopausal women with receptor positive primary breast cancer
To compare event free survival (EFS) between postmenopausal women treated with exemestane or anastrozole as adjuvant therapy.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman
Max and 99 years
International Breast Cancer Study Group (IBCSG)
Update Il y a 5 ans
IBCSG 23-01 : Essai de phase 3 randomisé comparant un curage axillaire à l'absence de curage axillaire, chez des patientes ayant un cancer du sein. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A randomized trial of axillary dissection versus no axillary dissection for patients with clinically node negative breast cancer and micrometastases in the sentinel node.
Country
France
organs
Sein
Specialty
Chirurgie
Essai clos aux inclusions
More information
Woman
Between 18 years
and 99 years
International Breast Cancer Study Group (IBCSG)
Update Il y a 5 ans
Étude PANACEA : étude de phase Ib/II visant à évaluer l’efficacité de MK-3475 et du trastuzumab chez des patientes ayant un cancer du sein métastatique HER2-positif résistant au trastuzumab. [essai clos aux inclusions]
PANACEA : Etude de phase Ib/II visant à évaluer l’efficacité de MK-3475 et du trastuzumab chez des patientes atteintes d’un cancer du sein métastatique HER2-positif résistant au trastuzumab
Country
France
organs
Sein
Specialty
Immunothérapie - Vaccinothérapie
,
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman Max 99 years
International Breast Cancer Study Group (IBCSG)
Update Il y a 5 ans
A Phase III Trial Evaluating the Role of Chemotherapy as Adjuvant Therapy for Premenopausal Women with Endocrine Responsive Breast Cancer Who Receive Endocrine Therapy
To compare ovarian function suppression plus tamoxifen or exemestane vs. chemotherapy plus ovarian function suppression plus tamoxifen or exemestane
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman
Between 18 years
and 99 years
International Breast Cancer Study Group (IBCSG)
Update Il y a 6 ans
Étude PANACEA : étude de phase Ib/II visant à évaluer l’efficacité de MK-3475 et du trastuzumab chez des patientes ayant un cancer du sein métastatique HER2-positif résistant au trastuzumab.
PANACEA : Etude de phase Ib/II visant à évaluer l’efficacité de MK-3475 et du trastuzumab chez des patientes atteintes d’un cancer du sein métastatique HER2-positif résistant au trastuzumab
Country
France
organs
Sein
Specialty
Immunothérapie - Vaccinothérapie
,
Thérapies Ciblées
Essai ouvert aux inclusions
More information
Woman Max 99 years
International Breast Cancer Study Group (IBCSG)
Update Il y a 5 ans
Chemotherapy for Radically Resected Loco-regional Relapse A randomized clinical trial of adjuvant chemotherapy for radically resected loco-regional relapse of breast cancer Chemotherapy vs. Observation
To evaluate the efficacy of adjuvant chemotherapy after radical local treatment of a first loco-regional recurrence of breast cancer. Treatment comparisons will be based upon the following endpoints: ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
International Breast Cancer Study Group (IBCSG)
Update Il y a 5 ans
Phase III trial of LHRH analog administration during chemotherapy to reduce ovarian failure following chemotherapy in early stage, hormone-receptor negative breast cancer
The primary objective of this study is to compare the rate of premature ovarian failure at two years following standard adjuvant or neoadjuvant chemotherapy with or without the addition of ovarian sup...
Country
None
organs
None
Specialty
None
unknown
More information